Charles Schwab’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-735
| Closed | -$7.8K | – | 3515 |
|
|
2023
Q4 | $7.8K | Hold |
735
| – | – | ﹤0.01% | 3531 |
|
|
2023
Q3 | $14.5K | Hold |
735
| – | – | ﹤0.01% | 3534 |
|
|
2023
Q2 | $56.3K | Buy |
+735
| New | +$56.3K | ﹤0.01% | 3407 |
|
|
2023
Q1 | – | Sell |
-553
| Closed | -$53.9K | – | 3589 |
|
|
2022
Q4 | $53.9K | Hold |
553
| – | – | ﹤0.01% | 3341 |
|
|
2022
Q3 | $143K | Hold |
553
| – | – | ﹤0.01% | 3196 |
|
|
2022
Q2 | $103K | Sell |
553
-3,051
| -85% | -$568K | ﹤0.01% | 3286 |
|
|
2022
Q1 | $353K | Hold |
3,604
| – | – | ﹤0.01% | 3174 |
|
|
2021
Q4 | $590K | Buy |
3,604
+117
| +3% | +$19.2K | ﹤0.01% | 3093 |
|
|
2021
Q3 | $952K | Sell |
3,487
-6,372
| -65% | -$1.74M | ﹤0.01% | 2892 |
|
|
2021
Q2 | $3.9M | Buy |
9,859
+67
| +0.7% | +$26.5K | ﹤0.01% | 2467 |
|
|
2021
Q1 | $5.29M | Buy |
9,792
+331
| +3% | +$179K | ﹤0.01% | 2277 |
|
|
2020
Q4 | $3.58M | Buy |
9,461
+181
| +2% | +$68.4K | ﹤0.01% | 2378 |
|
|
2020
Q3 | $3.51M | Buy |
9,280
+418
| +5% | +$158K | ﹤0.01% | 2245 |
|
|
2020
Q2 | $4.36M | Buy |
8,862
+1,018
| +13% | +$501K | ﹤0.01% | 2089 |
|
|
2020
Q1 | $2.88M | Buy |
7,844
+1,174
| +18% | +$431K | ﹤0.01% | 2106 |
|
|
2019
Q4 | $4.72M | Buy |
6,670
+157
| +2% | +$111K | ﹤0.01% | 2045 |
|
|
2019
Q3 | $4.18M | Buy |
6,513
+522
| +9% | +$335K | ﹤0.01% | 2057 |
|
|
2019
Q2 | $5.24M | Buy |
5,991
+425
| +8% | +$372K | ﹤0.01% | 1950 |
|
|
2019
Q1 | $3.22M | Buy |
5,566
+606
| +12% | +$350K | ﹤0.01% | 2187 |
|
|
2018
Q4 | $1.39M | Buy |
4,960
+438
| +10% | +$123K | ﹤0.01% | 2436 |
|
|
2018
Q3 | $2.17M | Sell |
4,522
-237
| -5% | -$114K | ﹤0.01% | 2404 |
|
|
2018
Q2 | $2.16M | Buy |
4,759
+331
| +7% | +$150K | ﹤0.01% | 2352 |
|
|
2018
Q1 | $2.6M | Buy |
4,428
+130
| +3% | +$76.5K | ﹤0.01% | 2226 |
|
|
2017
Q4 | $2.67M | Buy |
4,298
+174
| +4% | +$108K | ﹤0.01% | 2203 |
|
|
2017
Q3 | $3.8M | Buy |
4,124
+256
| +7% | +$236K | ﹤0.01% | 2021 |
|
|
2017
Q2 | $3.61M | Buy |
3,868
+279
| +8% | +$260K | ﹤0.01% | 1980 |
|
|
2017
Q1 | $3.41M | Buy |
3,589
+186
| +5% | +$177K | ﹤0.01% | 1969 |
|
|
2016
Q4 | $2.73M | Buy |
3,403
+115
| +3% | +$92.3K | ﹤0.01% | 2041 |
|
|
2016
Q3 | $2.78M | Buy |
3,288
+166
| +5% | +$140K | ﹤0.01% | 1973 |
|
|
2016
Q2 | $2.57M | Buy |
3,122
+64
| +2% | +$52.7K | ﹤0.01% | 1939 |
|
|
2016
Q1 | $3.4M | Buy |
3,058
+196
| +7% | +$218K | ﹤0.01% | 1750 |
|
|
2015
Q4 | $3.57M | Buy |
2,862
+166
| +6% | +$207K | ﹤0.01% | 1734 |
|
|
2015
Q3 | $3.64M | Sell |
2,696
-64
| -2% | -$86.5K | 0.01% | 1680 |
|
|
2015
Q2 | $4.97M | Buy |
2,760
+366
| +15% | +$659K | 0.01% | 1546 |
|
|
2015
Q1 | $3.87M | Sell |
2,394
-31
| -1% | -$50.1K | 0.01% | 1683 |
|
|
2014
Q4 | $1.84M | Sell |
2,425
-440
| -15% | -$335K | ﹤0.01% | 2058 |
|
|
2014
Q3 | $1.14M | Buy |
2,865
+383
| +15% | +$152K | ﹤0.01% | 2243 |
|
|
2014
Q2 | $1.5M | Buy |
2,482
+738
| +42% | +$446K | ﹤0.01% | 2132 |
|
|
2014
Q1 | $1.2M | Buy |
1,744
+409
| +31% | +$281K | ﹤0.01% | 2194 |
|
|
2013
Q4 | $870K | Buy |
1,335
+223
| +20% | +$145K | ﹤0.01% | 2325 |
|
|
2013
Q3 | $701K | Sell |
1,112
-13
| -1% | -$8.2K | ﹤0.01% | 2395 |
|
|
2013
Q2 | $357K | Buy |
+1,125
| New | +$357K | ﹤0.01% | 2659 |
|